Earnings History Data for Provention Bio, Inc. (PRVB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Provention Bio, Inc.

Provention Bio, Inc. is a biopharmaceutical company. It focuses on development of novel therapeutics and solutions to intercept and prevent immune-mediated disease. The company's product pipeline consists of PRV-031, PRV-6527, PRV-300, PRV-3279 and PRV-101 which are in clinical stage. Provention Bio, Inc. is based in NJ, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
03-11-2022	PM	7:00 AM ET (Nov 3)	PRVB	Provention Bio, Inc.	558.62	-0.34	-0.46	-0.43	Provention Bio GAAP EPS of -$0.34 beats by $0.08, revenue of $0.8M beats by $0.02M [11/3/2022 7:16 AM]	8.40	1.73 (25.92%)	7.52	0.85 (12.74%)	3.18 - 9.10	16,153,752	1,000,000	122,221
Provention Bio GAAP EPS of -$0.34 beats by $0.08, revenue of $0.8M beats by $0.02M [11/3/2022 7:16 AM] Provention climbs 27% as FDA proposes labeling for experimental diabetes drug [11/3/2022 12:36 PM] Provention Bio Reports Third Quarter 2022 Financial Results and Provides Business Update [Nov-03-22 07:00AM]
04-08-2022	PM	7:00 AM ET (Aug 4)	PRVB	Provention Bio, Inc.	255.52	-0.46	-0.49	-0.46	Provention Bio GAAP EPS of -$0.46 beats by $0.04, revenue of $0.75M beats by $0.05M [8/4/2022 7:28 AM]	4.26	0.28 (7.04%)	3.92	-0.40 (-9.26%)	3.19 - 8.04	487,702	510,000	51,552
Provention Bio Q2 2022 Earnings Preview [8/3/2022 12:36 PM] Provention Bio GAAP EPS of -$0.46 beats by $0.04, revenue of $0.75M beats by $0.05M [8/4/2022 7:28 AM]
05-05-2022	PM	7:00 AM ET (May 5)	PRVB	Provention Bio, Inc.	301.78	-0.35	-0.45	-0.52	Provention Bio GAAP EPS of -$0.35 beats by $0.11, revenue of $0.58M misses by $0.12M [5/5/2022 7:24 AM]	4.69	-0.24 (-4.87%)	4.93	0.0 (0.00%)	3.40 - 11.49	473,752	470,000	17,096
Provention Bio Q1 2022 Earnings Preview [5/4/2022 2:15 PM] Provention Bio GAAP EPS of -$0.35 beats by $0.11, revenue of $0.58M misses by $0.12M [5/5/2022 7:24 AM] Provention Bio Reports First Quarter 2022 Financial Results and Provides Business Update [May-05-22 07:00AM] Provention Bio, Inc. (PRVB) Reports Q1 Loss, Lags Revenue Estimates [May-05-22 08:25AM]
24-02-2022	PM	7:00 AM ET (Feb 24)	PRVB	Provention Bio, Inc.	416.37	-0.41	-0.44	-0.58	Provention Bio GAAP EPS of -$0.41 beats by $0.04 [2/24/2022 7:05 AM]	6.41	-0.16 (0.00%)	0.0	0.0 (0.00%)	3.40 - 14.50	916,112	1,016,575	0
Provention Bio Q4 2021 Earnings Preview [2/23/2022 12:07 PM] Provention Bio GAAP EPS of -$0.41 beats by $0.04 [2/24/2022 7:05 AM] Provention Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Feb-24-22 07:00AM] Provention Bio, Inc. (PRVB) Reports Q4 Loss, Tops Revenue Estimates [Feb-24-22 08:25AM]
04-11-2021	PM	7:00 AM ET (Nov 4)	PRVB	Provention Bio, Inc.	414.47	-0.43	-0.47	-0.56	Provention Bio EPS beats by $0.07, misses on revenue [11/4/2021 7:05 AM]	6.43	-0.23 (-3.45%)	6.44	0.01 (0.16%)	5.59 - 20.05	430,184	290,000	7,726
Provention Bio Q3 2021 Earnings Preview [11/3/2021 9:48 AM] Provention Bio EPS beats by $0.07, misses on revenue [11/4/2021 7:05 AM] Provention Bio names industry veteran as CFO [11/4/2021 8:13 AM] Provention Bio Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-04-21 07:00AM] Provention Bio Announces Appointment of Thierry Chauche as Chief Financial Officer [Nov-04-21 07:05AM] Provention Bio, Inc. (PRVB) Reports Q3 Loss, Misses Revenue Estimates [Nov-04-21 08:35AM]
05-08-2021	PM	7:00 AM ET (Aug 5)	PRVB	Provention Bio, Inc.	393.56	-0.46	-0.51	-0.45	Provention Bio EPS beats by $0.06 [8/5/2021 7:24 AM]	6.59	0.58 (9.55%)	5.98	-0.04 (-0.66%)	5.59 - 20.05	1,230,179	640,000	13,339
Provention Bio EPS beats by $0.06 [8/5/2021 7:24 AM] Provention Bio Reports Second Quarter 2021 Financial Results and Provides Business Update [Aug-05-21 07:00AM] Provention Bio, Inc. (PRVB) Reports Q2 Loss, Lags Revenue Estimates [Aug-05-21 08:45AM]
06-05-2021	PM	7:00 AM ET (May 6)	PRVB	Provention Bio, Inc.	457.57	-0.52	-0.48	-0.26	Provention Bio EPS misses by $0.05 [5/6/2021 7:11 AM]	7.01	-0.19 (-2.64%)	7.01	0.0 (0.00%)	6.36 - 20.05	1,171,624	890,000	6,933
Provention Bio EPS misses by $0.05 [5/6/2021 7:11 AM] Provention Bio, Inc. to Host Earnings Call [May-06-21 06:15AM] Provention Bio Reports First Quarter 2021 Financial Results and Provides Business Update [May-06-21 07:00AM] Provention Bio Reports First Quarter 2021 Financial Results and Provides Business Update [May-06-21 07:00AM]
25-02-2021	PM	7:00 AM ET (Feb 25)	PRVB	Provention Bio, Inc.	877.08	-0.58	-0.50	-0.22	Provention Bio EPS misses by $0.07 [2/25/2021 7:08 AM]	12.83	-1.82 (-12.42%)	14.84	0.19 (1.30%)	4.72 - 20.05	1,452,265	682,611	3,352
Provention Bio EPS misses by $0.07 [2/25/2021 7:08 AM] Provention Bio, Inc (PRVB) Q4 2020 Earnings Call Transcript [Feb-25-21 01:01PM] Provention Bio, Inc. to Host Earnings Call [Feb-25-21 05:45AM]
05-11-2020	PM	7:00 AM ET (Nov 5)	PRVB	Provention Bio, Inc.	755.84	-0.56	-0.40	-0.24	Provention Bio EPS misses by $0.14 [11/5/2020 7:12 AM]	13.36	-0.74 (-5.25%)	13.36	0.0 (0.00%)	4.72 - 18.50	439,718	408,407	4,061

06-08-2020	PM	4:05 PM ET (Aug 6)	PRVB	Provention Bio, Inc.	629.56	-0.45	-0.25	-0.32	Provention Bio EPS misses by $0.18 [8/6/2020 7:39 AM]	12.15	1.04 (9.36%)	11.21	0.10 (0.90%)	4.72 - 18.50	867,257	660,247	7,811